Company News: Page (1) of 1 - 12/11/17 Email this story to a friend. email article Print this page (Article printing at page facebook

IMBRUVICAŽ (ibrutinib) Data Provide Insights Into Its Potential Treatment Benefits for Previously-Treated Chronic Graft-Versus-Host Disease -- A Serious, Possibly Life-Threatening Condition

- Clinical results suggest that ibrutinib inhibits B cells and follicular helper T cells believed to play a critical role in treating chronic graft-versus-host disease (cGVHD), while preserving immune... (December 11, 2017)
This article is no longer available,but here are some related topics.

Page: 1

Related Keywords:Pro AV,Presentors,Business Issues,Presentation,People,Events,USA, Inc.,Medicine,Disease,Surgery,Pregnancy,Cancer,Surgery,Pregnancy,Science,Communications Technology,Medical,Biology,Genetics,Stem Cell,Cancer,Other,Men,Women,


Our Privacy Policy --- @ Copyright, 2015 Digital Media Online, All Rights Reserved